564 related articles for article (PubMed ID: 35133639)
1. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
[TBL] [Abstract][Full Text] [Related]
2. Repurposing drugs for treatment of alcohol use disorder.
Aubin HJ
Int Rev Neurobiol; 2024; 175():153-185. PubMed ID: 38555115
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatment of alcohol use disorder. Scientific evidence.
Attilia F; Perciballi R; Rotondo C; Capriglione I; Iannuzzi S; Attilia ML; Vitali M; Alessandrini G; Scamporrino MCM; Fiore M; Ceccanti M;
Riv Psichiatr; 2018; 53(3):123-127. PubMed ID: 29912214
[TBL] [Abstract][Full Text] [Related]
4. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
[TBL] [Abstract][Full Text] [Related]
5. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
Castrén S; Mäkelä N; Alho H
Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
Antonelli M; Sestito L; Tarli C; Addolorato G
Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
Soyka M; Müller CA
Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
[TBL] [Abstract][Full Text] [Related]
8. The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt JC
J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
[TBL] [Abstract][Full Text] [Related]
9. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
11. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
[TBL] [Abstract][Full Text] [Related]
12. Overview of Alcohol Use Disorder.
Kranzler HR
Am J Psychiatry; 2023 Aug; 180(8):565-572. PubMed ID: 37525595
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Kranzler HR; Soyka M
JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
[TBL] [Abstract][Full Text] [Related]
14. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
Williams EC; Matson TE; Harris AHS
Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
[TBL] [Abstract][Full Text] [Related]
15. Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.
Liang J; Olsen RW
Acta Pharmacol Sin; 2014 Aug; 35(8):981-93. PubMed ID: 25066321
[TBL] [Abstract][Full Text] [Related]
16. Anticraving therapy for alcohol use disorder: A clinical review.
Shen WW
Neuropsychopharmacol Rep; 2018 Sep; 38(3):105-116. PubMed ID: 30175522
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
Lohoff FW
Pharmacogenomics; 2020 Oct; 21(15):1117-1138. PubMed ID: 32807012
[TBL] [Abstract][Full Text] [Related]
18. Advances in Pharmacotherapy Development: Human Clinical Studies.
Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
[TBL] [Abstract][Full Text] [Related]
19. Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism.
Krishnan-Sarin S; O'Malley S; Krystal JH
Alcohol Res Health; 2008; 31(4):400-7. PubMed ID: 23584013
[TBL] [Abstract][Full Text] [Related]
20. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
Johnson BA
Biochem Pharmacol; 2008 Jan; 75(1):34-56. PubMed ID: 17880925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
